TMS and SPRAVATO are both options for depression that hasn’t responded to standard treatment, but they aren’t interchangeable.
When depression starts creeping back after treatment worked, a returning symptom isn’t a verdict — it’s a signal
When two antidepressants haven’t been enough, the next step shouldn’t be a faster guess. A treatment-resistant depression consult
Knowing you have anxiety but not knowing what kind is one of the most common patterns in clinical
Anxiety is maintained by avoidance — and effective treatment is the structured experience of doing the things the
SSRIs, SNRIs, buspirone, and benzodiazepines all treat anxiety — on different timescales, with different trade-offs. A board-certified PMHNP
Anxiety disorders affect 31% of U.S. adults across the lifespan — the most common mental health condition. A
Anxiety and ADHD can look almost identical from the outside — and about 40% of children with ADHD
Anxious treatment-resistant depression is the median pattern in real-world studies, not the outlier — 53 percent of STAR*D
ADHD is not a deficit of attention in any simple sense — it’s a neurodevelopmental disorder of self-regulation
Most California insurance plans cover TMS for treatment-resistant depression when the file is clean — but every plan
Most California commercial insurance plans cover TMS for treatment-resistant depression, but every plan requires prior authorization — and
iTBS, cTBS, theta-burst, Express TMS, accelerated iTBS — the naming around theta-burst protocols can confuse even informed patients.
Two FDA-cleared TMS technologies, two different coils, overlapping but distinct indications. A board-certified psychiatric specialist walks through how
TMS is FDA-cleared for depression, OCD, and smoking cessation — but not generalized anxiety disorder. Off-label use is
Forty-six percent of TMS responders are still in response at 12 months without further treatment. For the other
